Venetoclax resistance and acquired BCL2 mutations in chronic lymphocytic leukemia

被引：163
|
作者：
Tausch, Eugen [1 ]
Close, William [1 ]
Dolnik, Anna [2 ]
Bloehdorn, Johannes [1 ]
Chyla, Brenda [3 ]
Bullinger, Lars [2 ]
Doehner, Hartmut [1 ]
Mertens, Daniel [1 ,4 ]
Stilgenbauer, Stephan [1 ,5 ]
机构：
[1] Ulm Univ, Dept Internal Med 3, Ulm, Germany
[2] Charite, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany
[3] AbbVie, N Chicago, IL USA
[4] Deutsch Krebsforschungszentrum DKFZ, Cooperat Unit Mech Leukemogenesis, Heidelberg, Germany
[5] Saarland Univ, Sch Med, Dept Hematol Oncol & Rheumatol, Homburg, Germany
来源：
HAEMATOLOGICA | 2019年 / 104卷 / 09期
关键词：
ABT-199;
D O I：
10.3324/haematol.2019.222588
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
    Roberts, Andrew W.
    Davids, Matthew S.
    Pagel, John M.
    Kahl, Brad S.
    Puvvada, Soham D.
    Gerecitano, John F.
    Kipps, Thomas J.
    Anderson, Mary Ann
    Brown, Jennifer R.
    Gressick, Lori
    Wong, Shekman
    Dunbar, Martin
    Zhu, Ming
    Desai, Monali B.
    Cerri, Elisa
    Enschede, Sari Heitner
    Humerickhouse, Rod A.
    Wierda, William G.
    Seymour, John F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (04): : 311 - 322
  • [2] High-Level ROR1 and BCL2, Cancer-Stemness, and BCL2 Mutations Associate with Venetoclax Resistance in Chronic Lymphocytic Leukemia
    Ghia, Emanuela M.
    Rassenti, Laura Z.
    Choi, Michael Y.
    Chu, Elvin
    Widhopf, George F., II
    Kipps, Thomas J.
    BLOOD, 2019, 134
  • [3] Venetoclax targets BCL2 in chronic lymphocytic leukaemia
    Brower, Vicki
    LANCET ONCOLOGY, 2016, 17 (01): : E11 - E11
  • [4] Acquired BCL2 variants associated with venetoclax resistance in acute myeloid leukemia
    Brown, Fiona C.
    Wang, Xin
    Birkinshaw, Richard
    Chua, Chong Chyn
    Morley, Thomas
    Kasapgil, Sila
    Pomilio, Giovanna
    Blombery, Piers
    Huang, David C. S.
    Czabotar, Peter
    Priore, Salvatore F.
    Yang, Guang
    Carroll, Martin
    Wei, Andrew H.
    Perl, Alexander E.
    BLOOD ADVANCES, 2025, 9 (01) : 127 - 131
  • [5] Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax
    Kotmayer, Lili
    Laszlo, Tamas
    Mikala, Gabor
    Kiss, Richard
    Levay, Luca
    Hegyi, Lajos Laszlo
    Grof, Stefania
    Nagy, Tibor
    Barna, Gabor
    Farkas, Peter
    Weisinger, Julia
    Nagy, Zsolt
    Balogh, Alexandra
    Masszi, Tamas
    Demeter, Judit
    Sulak, Adrienn
    Kohl, Zoltan
    Alizadeh, Hussain
    Egyed, Miklos
    Pettendi, Piroska
    Gergely, Lajos
    Plander, Mark
    Pauker, Zsolt
    Masszi, Andras
    Matolcsy, Andras
    Szasz, Robert
    Bodor, Csaba
    Alpar, Donat
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [6] Multiple BCL2 mutations cooccurring with Gly101Val emerge in chronic lymphocytic leukemia progression on venetoclax
    Blombery, Piers
    Thompson, Ella R.
    Tamia Nguyen
    Birkinshaw, Richard W.
    Gong, Jia-Nan
    Chen, Xiangting
    McBean, Michelle
    Thijssen, Rachel
    Conway, Thomas
    Anderson, Mary Ann
    Seymour, John F.
    Westerman, David A.
    Czabotar, Peter E.
    Huang, David C. S.
    Roberts, Andrew W.
    BLOOD, 2020, 135 (10) : 773 - +
  • [7] Mechanisms of primary and acquired resistance to venetoclax in chronic lymphocytic leukemia (CLL).
    Murali, Ishwarya
    Cha, Justin
    Leshchiner, Ignaty
    Kuang, Yanan
    Vasquez, Kevin
    Khalsa, Jasneet
    Fernandes, Stacey M.
    Utro, Filippo
    Rhrissorrakrai, Kahn
    Levovitz, Chaya
    Danysh, Brian P.
    Slowik, Kara
    Jacobs, Raquel A.
    Paweletz, Cloud P.
    Parida, Laxmi
    Getz, Gad
    Brown, Jennifer R.
    CANCER RESEARCH, 2021, 81 (13)
  • [8] Detection of Multiple Recurrent Novel BCL2 Mutations Co-Occurring with BCL2 Gly101Val in Patients with Chronic Lymphocytic Leukemia on Long Term Venetoclax
    Blombery, Piers
    Thompson, Ella
    Tamia Nguyen
    Chen, Xiangting
    McBean, Michelle
    Birkinshaw, Richard W.
    Czabotar, Peter E.
    Thijssen, Rachel
    Anderson, Mary Ann
    Seymour, John F.
    Westerman, David Alan
    Huang, David C. S.
    Roberts, Andrew W.
    BLOOD, 2019, 134
  • [9] Not BCL2 mutation but dominant mutation conversation contributed to acquired venetoclax resistance in acute myeloid leukemia
    Xiang Zhang
    Jiejing Qian
    Huafeng Wang
    Yungui Wang
    Yi Zhang
    Pengxu Qian
    Yinjun Lou
    Jie Jin
    Honghu Zhu
    Biomarker Research, 9
  • [10] Not BCL2 mutation but dominant mutation conversation contributed to acquired venetoclax resistance in acute myeloid leukemia
    Zhang, Xiang
    Qian, Jiejing
    Wang, Huafeng
    Wang, Yungui
    Zhang, Yi
    Qian, Pengxu
    Lou, Yinjun
    Jin, Jie
    Zhu, Honghu
    BIOMARKER RESEARCH, 2021, 9 (01)
12345